Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Simone Biles Partners with Arcutis to Launch the Skin to Believe In Campaign, Raising Awareness of Seborrheic Dermatitis and Eczema, and Inspiring People to Explore Treatment Options

$ARQTPress releaseSep 29, 2026, 9:15 AM ETRead the release

Arcutis Biotherapeutics partnered with Olympic gymnast Simone Biles to launch the Skin to Believe In awareness campaign for seborrheic dermatitis and eczema. Biles discloses she uses ZORYVE foam and cream, and the release notes ZORYVE is the #1 prescribed branded topical therapy across atopic dermatitis, seborrheic dermatitis, and plaque psoriasis combined.

Key figures

Pivotal trials
eight pivotal trials, approximately 4,200 participants
Zoryve foam clear skin
77% of 458 patients clear/almost clear at 8 weeks vs 53% of 225 on vehicle
Addressable patients us
approximately 36 million Americans with inflammatory skin conditions
Zoryve cream clear skin
31% of 884 patients clear/almost clear at 4 weeks vs 14% of 453 on vehicle

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.